We are very excited to welcome Dan O’Shannessy to Cellsway’s advisory board

Dr. O’Shannessy has more than 20 years’ Executive Management experience in the fields of translational/precision medicine and diagnostics, specifically in oncology and liquid biopsies and recently founded TMDx Consulting. He has taken diagnostics from bench to bedside and identified biomarkers for patient selection in clinical trials, including regulatory strategies and agency interactions. Prior to his career in industry, Dr. O’Shannessy was a visiting fellow at the NIH and a Docent in Biochemistry at the University of Lund, Sweden. He has nearly 100 peer-reviewed publications and book chapters, >4000 citations and numerous issued patents and patent applications in the field of diagnostics. We are very pleased that Dr. O’Shannessy will offer Cellsway his strong expertise in liquid biopsy field as an advisory board member.

Leave a Reply

Your email address will not be published.